EP1526184 - Promoter sequences specific for cells of the B lymphoid lineage and pharmaceutical compositions containing the same [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.06.2006 Database last updated on 02.11.2024 | Most recent event Tooltip | 30.06.2006 | Application deemed to be withdrawn | published on 02.08.2006 [2006/31] | Applicant(s) | For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75654 Paris Cédex 13 / FR | [N/P] |
Former [2005/17] | For all designated states INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) 101, rue de Tolbiac 75654 Paris Cédex 13 / FR | Inventor(s) | 01 /
Tonelle, Cécile 9, avenue A. Rodin 13470 Carnoux en Provence / FR | 02 /
Moreau, Thomas 33, rue Falque 13006 Marseille / FR | 03 /
Chabannon, Christian 9, avenue Taine 13009 Marseille / FR | 04 /
Imbert, Jean 1, square de l'Eygalier, Parc des 7 collines 13011 Marseille / FR | [2005/17] | Representative(s) | Grosset-Fournier, Chantal Catherine Grosset-Fournier & Demachy 54, rue Saint-Lazare 75009 Paris / FR | [N/P] |
Former [2005/17] | Grosset-Fournier, Chantal Catherine Grosset-Fournier & Demachy, 54, rue Saint-Lazare 75009 Paris / FR | Application number, filing date | 03292663.6 | 24.10.2003 | [2005/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1526184 | Date: | 27.04.2005 | Language: | EN | [2005/17] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.04.2004 | Classification | IPC: | C12N15/63, A01K67/027 | [2005/17] | CPC: |
C07K14/70503 (EP);
A01K67/0271 (EP);
C12N15/63 (EP);
C12N15/85 (EP);
A01K2267/03 (EP);
A01K2267/0393 (EP);
A61K48/00 (EP);
C12N2799/027 (EP);
C12N2830/00 (EP);
| Designated contracting states | FR [2006/03] |
Former [2005/17] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR | Title | German: | Promotorsequenzen spezifisch für Zellen der B-lymphoiden Reihe und pharmazeutische Zusammensetzungen, welche diese enthalten | [2005/17] | English: | Promoter sequences specific for cells of the B lymphoid lineage and pharmaceutical compositions containing the same | [2005/17] | French: | Séquences de promoteurs spécifiques de la lignée cellulaire B lymphoide et compositions pharmaceutiques les contenant | [2005/17] | Examination procedure | 15.11.2005 | Application deemed to be withdrawn, date of legal effect [2006/31] | 06.03.2006 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2006/31] | Fees paid | Penalty fee | Penalty fee Rule 85b EPC 1973 | 14.12.2005 | M01   Not yet paid | Additional fee for renewal fee | 31.10.2005 | 03   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO02079418 (SANGAMO BIOSCIENCES INC [US], et al) [X] 1-14 * page 70 - page 72; example 2 * * page 7 - page 8; figure 3 *; | [X] - GISLER RAMIRO ET AL, "A human early B-cell factor-like protein participates in the regulation of the human CD19 promoter", MOLECULAR IMMUNOLOGY, (199910), vol. 36, no. 15-16, ISSN 0161-5890, pages 1067 - 1077, XP002274086 [X] 1-14 * abstract * DOI: http://dx.doi.org/10.1016/S0161-5890(99)00092-9 | [DX] - KOZMIK Z ET AL, "THE PROMOTER OF THE CD19 GENE IS A TARGET FOR THE B-CELL-SPECIFIC TRANSCRIPTION FACTOR BSAP", MOLECULAR AND CELLULAR BIOLOGY, (199206), vol. 12, no. 6, ISSN 0270-7306, pages 2662 - 2672, XP001117417 [DX] 1-14 * abstract * * page 2665 - page 2671; figure 9 * | [DX] - RIVA A ET AL, "In vivo footprinting and mutational analysis of the proximal CD19 promoter reveal important roles for an SP1/Egr-1 binding site and a novel site termed the PyG box.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.: 1950) UNITED STATES 1 AUG 1997, (19970801), vol. 159, no. 3, ISSN 0022-1767, pages 1284 - 1292, XP002274087 [DX] 1-14 * abstract * * page 1285, column R, paragraph 4 - page 1287, column L, paragraph 1 * | [X] - MOREAU T (REPRINT) ET AL, "Restriction of EGFP expression in the B-cell lineage, using a lentiviral vector with a sequence derived from the human CD19 promoter", EXPERIMENTAL HEMATOLOGY, (JUL 2003) VOL. 31, NO. 7, SUPP. [1], PP. 95-95. MA 105. PUBLISHER: ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA. ISSN: 0301-472X., Inst J Paoli I Calmettes, F-13009 Marseille, France, XP001180232 [X] 1-14 * abstract * | [X] - MOREAU T (REPRINT) ET AL, "Specificity of EGFP expression in the B-cell lineage using a lentiviral vector with a sequence derived from the human CD19 promoter", MOLECULAR THERAPY, (MAY 2003) VOL. 7, NO. 5, PART 2, PP. S437-S437. MA 1131. PUBLISHER: ACADEMIC PRESS INC ELSEVIER SCIENCE, 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA. ISSN: 1525-0016., Inst J Paoli I Calmettes, Ctr Therapie Cellulaire & Gen, F-13009 Marseille, France, XP001180234 [X] 1-14 * abstract * | [X] - MOREAU T (REPRINT) ET AL, "Restriction of EGFP expression to B-lymphoid progeny from human CD34(+) cells using a lentiviral vector with sequences derived from the human CD19 promoter.", BLOOD (16 NOV 2003) VOL. 102, NO. 11, PART 2, PP. 491B-491B. MA 5694. PUBLISHER: AMER SOC HEMATOLOGY, 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA. ISSN: 0006-4971., Inst J Paoli I Calmettes, Ctr Therapie Cellulaire & Genet, F-13009 Marseille, France;INSERM, U119, F-13258 Marseille, France, XP009027672 [X] 1-14 * abstract * |